212 related articles for article (PubMed ID: 28428207)
1. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
2. MRI Signal Intensity and Electron Ultrastructure Classification Predict the Long-Term Outcome of Skull Base Chordomas.
Bai J; Shi J; Zhang S; Zhang C; Zhai Y; Wang S; Li M; Li C; Zhao P; Geng S; Gui S; Jing L; Zhang Y
AJNR Am J Neuroradiol; 2020 May; 41(5):852-858. PubMed ID: 32381547
[TBL] [Abstract][Full Text] [Related]
3. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas.
Lin E; Scognamiglio T; Zhao Y; Schwartz TH; Phillips CD
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1509-1514. PubMed ID: 29903925
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Clinical Features and Outcomes of Skull Base Chordoma in Different Age-Groups.
Tian K; Wang L; Wang K; Ma J; Li D; Hao S; Yang Y; Du J; Jia G; Zhang L; Wu Z; Zhang J
World Neurosurg; 2016 Aug; 92():407-417. PubMed ID: 27237421
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery.
Hu YS; Lee CC; Wu CA; Lin CJ; Yang HC; Guo WY; Liu KD; Chung WY; Shiau CY; Wu HM
J Neurooncol; 2023 Jan; 161(1):45-56. PubMed ID: 36565364
[TBL] [Abstract][Full Text] [Related]
8. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.
Wei W; Wang K; Liu Z; Tian K; Wang L; Du J; Ma J; Wang S; Li L; Zhao R; Cui L; Wu Z; Tian J
Radiother Oncol; 2019 Dec; 141():239-246. PubMed ID: 31668985
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.
Yeom KW; Lober RM; Mobley BC; Harsh G; Vogel H; Allagio R; Pearson M; Edwards MS; Fischbein NJ
AJNR Am J Neuroradiol; 2013 May; 34(5):1056-61, S1. PubMed ID: 23124635
[TBL] [Abstract][Full Text] [Related]
10. Extent of Surgical Resection as a Predictor of Tumor Progression in Skull Base Chordomas: A Multicenter Volumetric Analysis.
Perez-Vega C; Akinduro OO; Ruiz-Garcia HJ; Ghaith AKA; Almeida JP; Jentoft ME; Mahajan A; Janus JR; Bendok BR; Choby GW; Middlebrooks EH; Trifiletti DM; Chaichana KL; Laack NN; Quinones-Hinojosa A; Van Gompel JJ
World Neurosurg; 2024 Jan; 181():e620-e627. PubMed ID: 37898264
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of the "Sekhar grading system for cranial Chordomas" in patients treated with pencil beam scanning proton therapy: an institutional analysis.
Hottinger AL; Bojaxhiu B; Ahlhelm F; Walser M; Bachtiary B; Zepter S; Lomax T; Pica A; Weber DC
Radiat Oncol; 2020 May; 15(1):96. PubMed ID: 32375820
[TBL] [Abstract][Full Text] [Related]
12. Natural Growth Dynamics of Untreated Skull Base Chordomas In Vivo.
Wang K; Xie SN; Wang L; Du J; Ma JP; Huo XL; Tian KB; Zhang LW; Zhang JT; Wu Z
World Neurosurg; 2020 Apr; 136():e310-e321. PubMed ID: 31926359
[TBL] [Abstract][Full Text] [Related]
13. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
Freeman JL; Kaufmann AB; Everson RG; DeMonte F; Raza SM
Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):27-36. PubMed ID: 29912434
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
[TBL] [Abstract][Full Text] [Related]
17. [Magnetic resonance (MR) imaging of chordoma and chondroma in the skull base--differential diagnosis by IR sequence].
Tashiro T; Inoue Y; Nemoto Y; Shakudo M; Mochizuki K; Yahata S; Tada T; Hata M; Oda J; Onoyama Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):589-93. PubMed ID: 1508632
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas.
Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J
World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670
[TBL] [Abstract][Full Text] [Related]
19. The Significance of Intraoperative Magnetic Resonance Imaging in Resection of Skull Base Chordomas.
Metwali H; Samii A; Gerganov V; Giordano M; Fahlbusch R; Samii M
World Neurosurg; 2019 Aug; 128():e185-e194. PubMed ID: 31003024
[TBL] [Abstract][Full Text] [Related]
20. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
